ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 10 filers reported holding ERYTECH PHARMA in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,731 | -25.5% | 10,590 | 0.0% | 0.00% | – |
| Q1 2023 | $10,378 | +196.9% | 10,590 | 0.0% | 0.00% | – |
| Q4 2022 | $3,496 | -41.7% | 10,590 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -50.0% | 10,590 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -36.8% | 10,590 | +1.7% | 0.00% | – |
| Q1 2022 | $19,000 | -24.0% | 10,415 | -1.9% | 0.00% | – |
| Q4 2021 | $25,000 | +108.3% | 10,615 | +430.8% | 0.00% | – |
| Q3 2021 | $12,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,314,656 | $690,000 | 0.03% |
| Vanguard Personalized Indexing Management, LLC | 59,839 | $33,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,005 | $6,000 | 0.00% |
| Asset Dedication, LLC | 4,000 | $2,000 | 0.00% |
| Ikarian Capital, LLC | 3,019 | $2,000 | 0.00% |
| UBS Group AG | 4,320 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,590 | $6,000 | 0.00% |
| Mariner, LLC | 59,472 | $33,000 | 0.00% |
| Citadel Advisors | 18,181 | $10,000 | 0.00% |